Volume 48, Issue 12 pp. 1489-1492
CASE REPORT

Indolent CD8+ primary cutaneous T-cell lymphoma involving the eyelid of an adolescent

Andrew N. Minzenmayer

Corresponding Author

Andrew N. Minzenmayer

Department of Dermatology, Baylor Scott and White Central Texas, Temple, Texas, USA

Correspondence

Andrew N. Minzenmayer, Department of Dermatology, Baylor Scott and White Central Texas, 2401 South 31st Street, Temple, TX 76508.

Email: [email protected]

Search for more papers by this author
Kirby Taylor

Kirby Taylor

Department of Ophthalmology, Baylor Scott and White Central Texas, Temple, Texas, USA

Search for more papers by this author
Chad D. Housewright

Chad D. Housewright

Department of Dermatology, Baylor Scott and White Central Texas, Temple, Texas, USA

Search for more papers by this author
Lindsay M. Bicknell

Lindsay M. Bicknell

Department of Dermatology, Baylor Scott and White Central Texas, Temple, Texas, USA

Search for more papers by this author
Sophia J. Hendrick

Sophia J. Hendrick

Department of Dermatology, Baylor Scott and White Central Texas, Temple, Texas, USA

Search for more papers by this author
Jonathan H. Tsai

Jonathan H. Tsai

Department of Ophthalmology, Baylor Scott and White Central Texas, Temple, Texas, USA

Search for more papers by this author
Andrew Siref

Andrew Siref

Department of Pathology, Baylor Scott and White Central Texas, Temple, Texas, USA

Search for more papers by this author
First published: 04 July 2021
[Correction added on 28 July after first online publication: Authors affiliations have been corrected in this current version.]

Abstract

Primary cutaneous acral CD8+ T-cell lymphoma (PCACTL) is currently a provisional entity defined as a rare cutaneous proliferation of atypical CD8+ lymphocytes that preferentially involves acral sites and has a good prognosis. We present a case of primary cutaneous CD8+ T-cell lymphoma involving the eyelid of an adolescent male. The case shares features with PCACTL, including indolent clinical behavior and expression of CD68 in a Golgi-associated dot-like pattern; however, other features differ significantly from PCACTL as currently defined by the World Health Organization (WHO). These features include ulceration, expression of CD56, granzyme B, and perforin, and a high proliferative index. Given these discrepancies, our case is currently best classified as a CD8+ primary cutaneous peripheral T-cell lymphoma, not otherwise specified. We review the differential diagnosis for this case and suggest expanding the definition of PCACTL.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.